Rademacher Katerina, Doric Zak, Haddad Dominik, Mamaligas Aphroditi, Liao Szu-Chi, Creed Rose, Kano Kohei, Chatterton Zac, Fu Yuhong, Garcia Joseph H, Vance Victoria M, Sei Yoshitaka J, Kreitzer Anatol, Halliday Glenda, Nelson Alexandra B, Margolis Elyssa, Nakamura Ken
Gladstone Institute for Neurological Disease, Gladstone Institutes, San Francisco, United States.
Graduate Program in Neuroscience, University of California San Francisco, San Francisco, United States.
Elife. 2025 Aug 26;13:RP98775. doi: 10.7554/eLife.98775.
Parkinson's disease (PD) is characterized by the death of substantia nigra pars compacta (SNc) dopamine (DA) neurons, but the pathophysiological mechanisms that precede and drive their death remain unknown. The activity of DA neurons is likely altered in PD, but we understand little about if or how chronic changes in activity may contribute to degeneration. To address this question, we developed a chemogenetic (DREADD) mouse model to chronically increase DA neuron activity and confirmed this increase using ex vivo electrophysiology. Chronic hyperactivation of DA neurons resulted in prolonged increases in locomotor activity during the light cycle and decreases during the dark cycle, consistent with chronic changes in DA release and circadian disturbances. We also observed early, preferential degeneration of SNc projections, recapitulating the PD hallmarks of selective vulnerability of SNc axons and the comparative resilience of ventral tegmental area axons. This was followed by the eventual loss of midbrain DA neurons. Continuous DREADD activation resulted in a sustained increase in baseline calcium levels, supporting a role for increased calcium in the neurodegeneration process. Finally, spatial transcriptomics from DREADD mice examining midbrain DA neurons and striatal targets, and cross-validation with human patient samples, provided insights into potential mechanisms of hyperactivity-induced toxicity and PD. Our results thus reveal the preferential vulnerability of SNc DA neurons to increased neural activity and support a potential role for increased neural activity in driving degeneration in PD.
帕金森病(PD)的特征是黑质致密部(SNc)多巴胺(DA)神经元死亡,但在其死亡之前并导致其死亡的病理生理机制仍不清楚。DA神经元的活动在PD中可能发生改变,但我们对活动的慢性变化是否以及如何导致神经元变性了解甚少。为了解决这个问题,我们开发了一种化学遗传学(DREADD)小鼠模型来长期增加DA神经元的活动,并使用离体电生理学证实了这种增加。DA神经元的慢性过度激活导致光周期中运动活动的持续增加和暗周期中的减少,这与DA释放的慢性变化和昼夜节律紊乱一致。我们还观察到SNc投射的早期、优先变性,重现了SNc轴突选择性易损性和腹侧被盖区轴突相对韧性的PD特征。随后是中脑DA神经元的最终丧失。持续的DREADD激活导致基线钙水平持续升高,支持钙增加在神经变性过程中的作用。最后,对DREADD小鼠的中脑DA神经元和纹状体靶点进行空间转录组学分析,并与人类患者样本进行交叉验证,为多动诱导毒性和PD的潜在机制提供了见解。因此,我们的结果揭示了SNc DA神经元对神经活动增加的优先易损性,并支持神经活动增加在驱动PD变性中的潜在作用。